Specialty Pharma Journal Specialty, Precision & Technology
No job listings found.
Breaking News
- Vargatef Plus Docetaxel Could be an Option After Failure of Immunotherapy in Lung Cancer
- Merck to Acquire Privately Held Antelliq Group for $2.4 Billion
- Bellicum Reports Safety Results and Promising Activity of Its Controlled CAR-T Candidate BPX-601 in Patients with Advanced Pancreatic Cancer
- Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi
- Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency
- Dragonfly Therapeutics Announces Celgene In-license of First Two TriNKET Immunotherapy Drug Candidates
- Sunovion and PsychoGenics Announce Positive Results from Pivotal Phase 2 Study of Investigational Agent SEP-363856 for the Treatment of Schizophrenia
- AMAG Pharmaceuticals Enters Into Definitive Merger Agreement to Acquire Perosphere Pharmaceuticals
- FDA Grants Fast Track Designation to Lilly’s Baricitinib for the Treatment of Systemic Lupus Erythematosus
- New Phase 3 Data Demonstrate Superiority of Tremfya vs Cosentyx in Delivering PASI 90 Responses in Plaque Psoriasis